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Health-Related Quality of Life (HRQoL) scores vary 
with treatment and may identify potential defaulters 




Nigeria ranks third among the 22 high-burden TB countries in the world. With the availability of  effective treatment strategies, and 
more patients surviving the disease, assessment of  Patient Reported Outcomes (PROs) has become imperative to assist with patient 
evaluation of  measured outcomes and thus improve morbidity. Literature is scarce on assessment and impact of  chemotherapy on 
Health-Related Quality of  Life (HRQoL) for patients with tuberculosis. 
Aim
This study evaluates the variation in Health-Related Quality of  Life (HRQoL) in pulmonary TB patients during the intensive phase of  
treatment.
Methods
We recruited patients with pulmonary TB (PTB), from 3 different TB clinics across Ife Ijesha Zone, Osun State, Nigeria. Consenting 
patients were administered Short Form-36 HRQoL questionnaire at recruitment and at the end of  intensive phase of  treatment. 
HRQoL scores were compared at these two-time points, the degrees of  changes were calculated and relationships with some. Directly 
Observed Therapy-Short (DOTS) course outcome measures were obtained. Logistic regression was used to identify factors associated 
with greatest change in HRQoL scores.
Results
Of  the 130 recruited patients, we analysed data for 126 patients who met the inclusion criteria. Mean age was 36.7(SD15.5). The 
overall mean HRQoL score obtained at enrolment was 43.18 (SD 17.2) and 60.22 (SD19.83) at end of  2 months; mean change =17.04 
p<0.001). The least change was on the emotional well-being domain (mean change = 4.24, p=0.05). Predictor of  significant change in 
HRQoL scores were previous history of  TB, HIV status and TB severity, p<0.05 each. High physical functioning score was a strong 
predictor of  defaulters (OR = 5.3; 95%CI: 2.11-9.05, p = 0.01).
Conclusion
Emotional domain is least affected by PTB while younger patients with no physical impairment are more likely to default treatment. 
Various aspects of  HRQoL can be a useful tool for patient’s evaluation and outcome prediction.
Key Words: HRQoL, DOTS, defaulters, TB, treatment, physical function
Introduction
Quality of  life (QoL) is a broad, multidimensional concept 
incorporating in a complex way, the person’s physical 
health, psychological state, level of  independence, social 
relationships, personal beliefs and their relationship to salient 
features of  the environment1,2. It describes the satisfaction 
felt by an individual with the various aspects of  his or her 
life1,2. TB has remained a major public health threat globally 
with the developing countries bearing the greatest brunt3. 
Nigeria ranks third among the 22 high-burden TB countries 
in the world, and first in Africa ahead of  South Africa3. 
With the development and availability of  effective treatment 
strategies for TB and with more patients surviving the 
disease and living longer, a shift in the traditional evaluation 
of  patients based on clinical and microbiological outcome 
is imperative. TB affects the Health-Related Quality of  Life 
(HRQoL) both before and during treatment4-10. If  the gains 
of  the current TB control efforts are to be sustained, it is 
important that TB management should embrace measures 
to improve morbidity outcomes. The assessment of  Patient 
Reported Outcomes (PROs) has become more accepted and 
valued in the disease management and outcome evaluation1,6. 
Despite the huge number of  TB patients in Nigeria, literature 
is scarce on information on the quality of  life for patients 
with tuberculosis and especially the impact of  chemotherapy 
on patients’ HRQoL. This is quite important as patients’ 
perception of  their disease and the improvement brought by 
anti TB drugs will assist in ensuring compliance with treatment 
and thereby prevent emergence of  resistance strains. This 
study investigates the HRQoL among treatment-naive TB 
patients to determine the predictors of  improvement in their 
quality of  life and how it varies with treatment outcome by 
the end of  intensive phase of  treatment.
Methods
Study Design and Population
This was a cross sectional study conducted among treatment-
naive TB patients in three Directly Observed Therapy 
(DOT) clinics within 2 to 16 km from each other in Ile 
Malawi Medical Journal 30 (4); 283-290 December 2018 Health Related Quality of Life in TB patients on treatment  284
https://dx.doi.org/10.4314/mmj.v30i4.12
Ife, Osun State, Nigeria (the TB Clinic, Obafemi Awolowo 
University Teaching Hospitals Complex (OAUTHC), Ile Ife, 
Enuwa TB clinic and Moro TB clinic). Ethical Clearance 
was obtained from the OAUTHC Ethics and Research 
Committee (ERC/2012/11/06 No,) and Ministry of  Health, 
Osun State, while informed Consent was obtained from 
each participant/Legally Accepted Representative (LAR), 
before commencement of  the study. The study design is 
as illustrated in S1 in line with Strengthening the Reporting 
of  Observational studies in Epidemiology (STROBE) 
guideline12.
Consenting patients with pulmonary tuberculosis diagnosed 
according to the Nigerian National Tuberculosis and Leprosy 
Control Program Guidelines, and who met the inclusion 
criteria were consecutively recruited at each of  the study 
clinics11. The inclusion criteria included: Participants aged 
15 and above who gave consent/assent to participate in the 
study; who were not already started on anti-TB treatment; 
and were resident in study locality. Patients less than 15 
years or whose LAR refused consent, those already on TB 
treatment, those with co-existing medical conditions like 
renal failure, liver disease, and pregnancy or anyone who had 
difficulties in understanding the questionnaire were excluded 
from the study. Both smear positive and smear negative PTB 
patients, new and retreatment cases and those with HIV 
positive result who met the inclusion criteria were recruited.
Measurements and Data Collection
Trained research assistants interviewed the enrolled 
participants to obtain the requisite data including age at last 
birthday, sex, Body Mass Index, place of  domicile, history 
of  tobacco use, HIV status and duration of  TB symptoms 
before presenting to the health facility. To ascertain the socio-
economic status of  the individual, the method that rated the 
occupation and educational qualification was used12.
The HRQoL was assessed using the interviewer- 
administered Short-Form 36(SF-36) questionnaire. The 
SF-36 questionnaire is a generic instrument designed to 
assess in a broad sense, the impact of  disease on health. 
It has been used extensively in most assessment of  TB 
patients5-7,13-15. The validated and pre-tested English version 
and a validated back-translated previously piloted Yoruba 
version (concurrent validity scores for scales and domains 
0.749 and 0.902), of  the questionnaires were used16.  The 
SF-36 questionnaire contains 36 questions grouped into 
8 subscales, covering multiple aspects of  health, including 
physical function, social function, general health, vitality 
and limitations due to physical, emotional functioning, role-
emotional and mental health12-15. From the eight subscales, 
the physical component summary (PCS), mental component 
summary (MCS) and overall scores can be calculated. For 
each subject, the original response (scored between 0 to 5) 
on each question is recoded on a scale of  0 to 100, with 
100 representing the highest level of  functioning possible15. 
From these recoded values, the items scores were averaged 
and combined to form the 8 subscales. Aggregate scores 
were compiled as a percentage of  the total points possible15. 
Scores from the 8 subscales were also aggregated to generate 
the Physical Health Component Score and the Mental Health 
Component Score. 
To assess severity of  TB, a validated TB score system, 
Bandim TB score (BTB) consisting of  13 items of  signs 
and symptoms, was used17. The signs and symptoms used in 
this scoring system include cough, haemoptysis, fever, chest 
pain, positive finding on auscultations, the body mass index 
(BMI), mid upper arm circumference and others. Each item 
is scored one mark if  present, and the sum of  all the scores 
was used to classify severity as follows: Severity Class(SC), 
SC-I for TB score of  0-5; SC-II for TB score of  6-7; and 
SC-III for score of  8 points and above. The patients were 
subsequently commenced on anti TB drugs in accordance 
with the National TB Control Guideline in Nigeria11. The 
quality of  life (total and domain) assessments were evaluated 
at start of  treatment and after two months of  treatment (end 
of  intensive phase).
Statistics 
Information obtained from the participants was analysed 
using Statistical Package for Social Sciences (SPSS) software 
version 19 for Windows®. Frequencies of  the various 
numerical variables such as age, duration of  symptoms 
were analysed using mean, median and standard deviations. 
Variables with normal distribution were analysed with 
parametric statistical tools while those that are of  non-
normal distribution were analysed with non-parametric 
tools like Mann Whitney U test. To determine the level of  
significance for the variables, Chi-square statistics or Fisher 
exact test was used for multiple categorical variables. To 
interpret possible significance of  the outcomes amongst 
group variables during treatment, Norm Based Score 
(NBS) ≥ 3-point change in the health domain scales and 
component summary measures represented minimal clinically 
important difference (MCID)15. Hence, individuals with 
higher point change implied higher degree of  improvement. 
A score on a health domain scale or component summary 
measure that was less than 47 NBS point was considered 
indicative of  impaired function within that health domain 
or dimension15. Logistic regression analysis was used to 
determine the independent variables that were predictive of  
the greatest improvement in the quality of  life scores after 
the intensive phase of  treatment compared to baseline, using 
the backward elimination method. Mann Whitney U test was 
used to test for relationship between HRQoL scores among 
defaulters and non-defaulters at the end of  intensive phase. 
Level of  significance was put at p<0.05 for all the statistical 
analyses, with a minimum power of  80% for the confidence 
interval of  95%.
Results
Characteristics of the study population
Of  the 130 PTB patients recruited, four had incomplete 
data and were excluded from further analysis, (SI appendix). 
Analyses were done for the remaining 126 participants. The 
mean age of  study participants was 36.7(SD15.5) years with 
95(74%) of  them between the ages of  20 and 49 years old. 
(Table 1) There were slightly more males 68(53.5%) than 
females. Most of  the participants 118(94%) had a BMI of  less 
than 24.9. Table 1 further highlights the socio-demographic 
and clinical characteristics of  the study participants. Of  the 
total studied, 13(10%) had a history of  tobacco use, 8(6%) 
were HIV positive while 26(20%) had been previously 
treated for TB. History of  symptoms consistent with PTB 
had been present for 1 to 6 months in 79(61%) of  the study 
participants. Majority 103(82%) were in severity class I. 
Overall, 115(91.5%) were smear positive while 11(8.5%) had 
smear negative TB.
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Table 1: Socio-demographic characteristics of study participants
Quality of life scores among TB patients
The overall mean quality of  life score obtained in all study 
participants at enrolment was 43.18 (SD 17.2). By the end 
of  the intensive phase 17 (13.49%) patients had defaulted 
(11 smear positive and 6 smear-negative). For the remaining 
109 (86.51%), the overall mean quality of  life score at the 
end of  intensive phase was 60.22 (SD19.83); mean change 
(MCID)=17.04 p<0.001), Table 2.
Before therapy was commenced, patients had highest 
HRQoL score on the Pain domain, 56.65 (SD16.60) and 
lowest in the Role limitation domain, 17.44 (SD33.74). At 
the end of  intensive phase, patients had the largest increase 
in the Role limitation domain (MCID 36.8, p<0.001) and the 
least and insignificant change on the emotional well-being 
domain (MCID= 4.24, p=0.05). There were significant 
changes in the other domains as shown in Table 2.
Table 2: HRQoL scores at recruitment and at the end of intensive 
phase
Although the baseline total HRQoL scores between the 
defaulters and those that completed the intensive phase 
of  treatment were similar: median (IR) 46.7(SD 17.2) 
and 43.7(SD 17.1) respectively, p=0.06, defaulters had 
significantly higher score on physical functioning at 0 month 
compared with those who did not default, (62.3 (SD 20.1) 
and 49.4 (SD23.6) respectively, p =0.03), (Figure 1).
Figure 1: HRQoL scores for defaulters and non- defaulters at the 
end of intensive phase
 Non defaulters  Defaulters
*PF: Physical functioning, RL: Role Limitation, RLE: Role 
limitation emotional, E:Energy,EWB: Emotional
wellbeing, SF: Social functioning, PA: Pain, GH: General Health, 
PHC: Physical Component Summary, MHC: Mental Component 
Summary * p value less than 0.05, Mann Whitney U test was used.
HRQoL scores were also compared among 91.8% (90/98) 
who were smear converted, and 8.2%(8/98) that remained 
smear positive at the end of  intensive phase. There were 





Age (years) 126(100) 67 (53.5)  59(46.5) 0.371
15 -20 10(7.9) 3 (4.5) 7 (11.9)
20 to 29 39(31.0) 21(31.3) 18(30.5)
30 to 39 30(23.8) 14(20.9) 16(27.1)
40 to 49 26(20.6) 17(25.4) 9(15.3)
50 to 59 9(7.1) 4(6.0) 5(8.5)
60 and above 12 (9.5) 8(11.9) 4(6.8)
BMI 0.342
<18.5 53(42.1) 29 (42.6) 24(42.1)
18.5 to 24.9 65(51.6) 37(54.4) 27(47.4)
25.0 to<29.9 5(4.0) 1(1.5) 4(7.0)
≥30.0 3(2.4) 1(1.5) 2(3.5)









HIV positive 8(6.3) 3 (4.5)




Tobacco use 13 (10.3) 11 (16.4) 2(3.4)
No Tobacco 
use





0 to <1 32(25.4) 17 (25.0) 15 (25.4)
1 to 6 77(61.1) 40 (58.8) 37 (62.7)




I 103(82.0) 55(82.1) 48(81.4)
II 14(11.0) 6(8.9) 8(13.6)
III 9(6.9) 6(8.9) 3(5.0)
Domains Mean Score (SD) 
at 0 month






Physical function 50.47(23.44) 61.32(29.87) 10.84 <0.001
Role limitation 
(Physical)
17.4433.74) 54.26(44.65) 36.82 <0.001
Role limitation 
(emotional)
19.75(34.26) 54.06(44.02) 34.30  <0.001
Energy fatigue 50.08(21.61) 60.08(19.16) 10.00 <0.001
Emotional 
wellbeing
55.45(16.60) 59.69(18.57) 4.24 0.05
Social function 49.32(22.28) 61.34(20.34) 12.02 <0.001
Pain 56.65(26.48) 69.61(22.67) 12.97 <0.001
General health 43.80(18.87) 60.47(19.27) 16.67 <0.001
Physical 
Component
42.09(19.97) 61.41(24.28) 19.32 <0.001
Mental 
Component
43.65(18.09) 58.79(19.86) 15.14 <0.001
Overall HRQoL 43.18(17.20) 60.22(19.83) 17.04 <0.001
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Components summary scores and overall scores between 
the two groups.
Table 3: Factors associated with mean change in QOL Scores at 
completion of intensive phase treatment
Table 4: Adjusted effects of predictor variables on change in 
QOL measures
p<0.05, ** p<0.01,***p<0.001
‡Categories eliminated by backward multiple regression analysis: Age = <20 years; 
no previous history of TB; BTB score ≥ 6, Smear negative TB, normal BMI; No 
tobacco use; negative HIV status; Duration of symptoms ≤ 1 month.








15-20 18.98 16.91 20.60
20-29 19.71 18.05 18.35
30-39 23.17 18.25 21.75
40-49 14.88 11.36 12.08
50-59 0.42 -3.74 -3.88
≥60 30.91 18.12 23.78
p-value 0.28 0.34 0.15
Sex
Male 20.59 15.98 18.22
Female 18.30 14.09 16.00












0 to ≤1         30.56 26.18    26.66
>1 to 6         13.91 11.72     12.62
>6         23.13 10.50     17.60
p value         0.03 0.03                                               0.03
BMI
Underweight        25.17 20.25          23.13
Normal        15.83 11.78          12.92
Overweight/
Obese
        8.98 5.32          9.14
p-value         0.14 0.14              0.08
Tobacco 
exposure
Tobacco use       15.67 16.34         16.44
No Tobacco 
use
      19.73 15.00         17.11
p-value       0.65 0.87          0.93
HIV Status
Positive      7.66 0.07         2.57
Negative     20.10 16.14        18.00
p-value       0.27 0.01         0.02
Smear Status
Negative     11.3 5.8           7.5
Positive  19.9 15.6         17.7
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Factors associated with greatest change in HRQoL 
scores (MCID)
We compared the differences in scores at recruitment 
(before initiating treatment) and at the end of  intensive 
phase of  treatment across different demographic and clinical 
parameters to determine factors that accounted for greatest 
improvement in the HRQoL scores, (Table 3). Participants 
with previous history of  TB were associated with positive 
change in scores in the two Health components and overall 
HRQoL scores, (p=0.001 respectively). Similarly, the 
duration of  symptoms of  less than four weeks at recruitment 
(before initiating treatment) was associated the largest 
changes in physical and mental health and overall HRQoL 
scores, compared with those with longer symptom duration, 
(p=0.03). Smear positive status at recruitment was associated 
with significant change in the overall score compared with 
smear negative. Age, sex, ethnicity, baseline BMI, smoking 
and HIV were not associated with notable or significant 
changes in HRQoL scores, (p>0.05), Table 3. The TB/
HIV co-infected patients were noted to have lower scores 
in domain and overall scores compared with PTB patients 
alone (p=0.01 and 0.02 respectively). Table 3.
TB severity score and HRQoL
The relationship between TB severity using the Bandim 
TB score and HRQoL was noted to show both a linear and 
quadratic relationship (Figure 2). Overall HRQoL score was 
influenced by the BTB score. As the BTB score increased, 
the mean value of  the HRQoL domains and overall score 
increased up to score of  6 following which there was a 
decline.
Figure 2: Scatter plots of Bandim TB severity score against QOL 
scores with smoothed plots
Predictors of greatest change in HRQoL scores
Using the MCID score, Table 4 shows the predictors 
of  significant change in the physical and mental health 
components and the overall scores. Previous history of  TB 
was a strong predictor of  significant change in the physical 
health component and overall scores, (p<0.05). HIV positive 
status was associated with a marked reduction in mental 
health and overall HRQoL scores (p<0.05). The TB severity 
score, as measured by Bandim TB Score was a significant 
predictor of  physical and mental health change and overall 
scores, baseline Smear status was a significant predictor of  
all the HRQoL domains with greatest impact on the mental 
health component, Table IV.
Table 5: Association between socio-demographic variables, QOL 
and treatment default at end of 2 months
Effect of HRQoL on default rates
Table 5 shows bi-variate and multiple regression analyses 
of  factors associated with default among the cohorts. Age 
and baseline score of  physical functioning domain were 
significantly associated with default. However, gender, past 
medical history of  TB, previous tobacco use, TB severity 
class and duration of  illness before recruitment were not 







p-value  Odds 
ratio           
95% CI  p-value  
Variables Bivariate analysis Logistic  predictors of  non 




30              
11(64.7%) 42(31.5%) 0.04               0.3                    0.08 - 
1.11            
0.9  
30 and 
above           
6 (35.3%) 91 (68.5%) 1
Sex
M                                 7(41.2%) 72(54.1%)  0.08       2.1                0.9- 3.5 0.08          
F 10(58.8%) 61 (45.9%) 1
Previous 
TB
Yes 5(29.1%) 25(18.8%)   0.07         0.5             0.1-1.2   0.9
No 12(70.9%) 108(81.25) 1
Smoking 
History
Yes 3(17.6%) 12(9%) 0.08 3.4 
           
0.9-4.7 
           
0.07
No 14(82.4%) 119(91%) 1
TB severity 
class
I 10(58.8%) 99(74.4%) 0.06 1.9 0.9-3.5 0.06
II 4(23.5%) 21 (15.7%) 1.2 0.3-2.4  




0-3                              7(41.2%) 57(42%) 0.9 2.1 
          
0.9-3.3 0.09
3-6           6(35%) 27(20.3%) 1.9   0.07-








45             
2(11.6%) 73(54.9%) 0.03 5.3            1.11 - 
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of  two months(p<0.05). Multiple regression analysis of  
predictors of  default identified PF score of  more than 45 as 
having greater chances of  defaulting treatment (OR = 5.3; 
95%CI: 2.11-9.05, p = 0.01). Defaulters also tended to be 
younger (median age, IR 29.3(10.4) years) compared with 
those who completed intensive phase treatment (median age 
36.9(16.7) years), p = 0.04
Discussion
This cross-sectional study among a sample of  both smear 
positive and smear negative TB patients in Nigeria provided 
insights into their HRQoL scores and how these vary with 
the treatment (end of  intensive phase). We noted that there 
were significant changes in the total HRQoL scores in all 
domains and the two components, except the emotional 
well-being domain. Defaulters had significantly higher 
score on physical functioning compared with those that 
completed the intensive phase. HIV negative status, mild TB 
as measured by Bandim TB score, sputum smear status and 
previous history of  TB were predictors of  largest increase/
greatest improvement in HRQoL scores at the end of  two 
months of  treatment.
Though no comparisons with healthy individuals were done 
before commencing therapy, it has been shown that TB 
patients have lower scores on most domains tested, compared 
with healthy individuals5-7,13,18,19. Component summary scores 
obtained in those studies among TB patients were higher 
than what we reported, but our findings were similar to 
report from South Africa20. The scores in both our study 
and the South African study reported lower than the norm-
based scoring point considered to be indicative of  impaired 
function within that health domain or dimension15. This is 
probably reflective of  the similarities in socio-economic 
parameters. We observed a higher mean score on the mental 
health component compared with the physical health 
component. This is consistent with earliest observations by 
Chamla18 where patients also had lower score on physical 
health component. Following two completed months of  
anti-TB medications, in addition to sputum conversion in the 
majority of  the patients, chemotherapy also had a positive 
effect on HRQoL. Patients had significant improvement on 
all domains, the physical and mental components and over 
all scores, except emotional well-being domain. The mean 
change in physical component summary score at the end of  
two months was larger than what was observed in the mental 
component summary score. It appeared that though physical 
health seemed to be more affected prior to treatment, it 
improved by the end of  intensive phase of  treatment. This 
trend has been observed before18,19,-21.  It may therefore 
mean that the emotional problems and anxiety mainly due 
to stigma, fear of  rejection and sometimes loss of  income 
that these individuals experience does not abate but could 
become heightened7-10.
As shown in this study, defaulters had better score on 
physical functioning. Patients with higher score on physical 
functioning had a five-fold chance of  defaulting. Better 
perception of  their physical health, howbeit wrongly and 
reduced limitation of  physical functioning due to the disease, 
may make the individual doubtful of  the correctness of  their 
diagnosis. These perceptions of  the patients, the initial rapid 
resolution of  symptoms and side effects of  medications may 
encourage default to treatment. Despite the small number, 
it may be right to state that individuals with higher score 
on physical functioning domain may have issues complying 
with treatment. Since the noted group are somewhat still 
agile, and do not consider themselves as that sick, they may 
find it more appropriate to embark on income fetching 
ventures rather than daily hospital visits for medications. 
Such individuals should be recognized and should receive 
personalized counsel. Within our context, where the 
pharmacy-driven programme22 is not practiced, alternatives 
like Video observation of  therapy may also be considered23,24.
In a multivariable analysis, history of  previous TB, baseline 
severity score up to 6, negative smear status and HIV negative 
status were significantly positively correlated with increase 
in QoL score at the end of  two months. The expectation 
would have been that previously treated patients will report 
poorer HRQoL due to complications such as lung fibrosis25. 
However, it turned out not to be so. Could this be a case 
of  passing through the same road twice and now better 
accustomed to it, or whether it was due to development 
of  coping strategies or the quality and satisfaction of  care 
previously received for TB? It is difficult to say. However, 
since majority of  our study participants have only been 
treated once, and they had mild disease, the usual post 
tuberculosis sequel like fibrosis may be minimal with limited 
or no functional impairment compared with what those with 
multiple treatments and drug resistance TB may experience26. 
This may partly explain why the greatest improvement was 
recorded in the physical component summary. Conversely, 
HIV positive co-infected TB patients had a significant lower 
change on the mental component summary and overall 
scores compared with those who were HIV negative.
Issues concerning HRQoL in TB/HIV co-infected individuals 
have not been straight forward due to the confounding 
impact of  other variables like use of  antiretroviral drugs, 
and concurrent opportunistic conditions27. In consonance 
with our findings, report from a South African study, with 
4900 participants who had TB, of  whom 60% were HIV 
co-infected, found that HIV infection was associated with a 
significantly lower health status20.
Mild disease was positively correlated to greatest 
improvement in the two components and overall scores, and 
smears positive status was significantly negatively correlated 
with those same parameters. These two predictors had the 
lowest p values, indicating their relative strength in predicting 
marked improvement in the HRQoL. A less severe disease 
is likely to have minimal structural damage and functional 
impairment26. The absence of  functional impairment may 
ameliorate any psychological issues in mild/moderate disease.
Consistent with our finding, Dhingra et al28 and Sule et al29 
demonstrated a higher HRQoL scores among smear negative 
TB patients compared with smear positive ones. It has also 
been shown that the presence and load of  Mycobacterium 
tuberculosis correlate with symptom severity30. Taken together, 
individuals with smear positive TB are likely to have more 
symptoms and this could affect the degree of  improvement 
in the HRQoL with treatment as shown in our study.
This study is limited in that comparisons with healthy 
individuals and an end of  treatment assessment of  HRQoL at 
6 months were not done. Although, there were improvements 
in 2 and 6 months scores following treatment, many patients 
still have residual impairment as reported by Aggarwal et 
al31. Moreover, other reports had shown no difference in the 
two and six months scores32,33. However, report by Bauer 
et al reported that most impairments in HRQoL are most 
pronounced during the weeks after diagnosis and treatment 
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initiation, but is no longer evident after two months6. We 
did not evaluate for the variations that could have been due 
to drug resistant strains as well. Despite these limitations, 
we have shown that HRQoL scores improve significantly, 
except emotional well-being, after two months of  treatment. 
Even though physical component summary score seems to 
be worse before treatment, it appeared to greatly appreciate 
by the end of  intensive phase. Patients with better physical 
functioning had five-fold chance of  defaulting. This 
interaction between default and HRQoL, to our knowledge, 
has not been previously recognized before in most HRQoL 
studies in TB. The impact of  anti-TB medications on the 
HRQoL scores was obvious. Nevertheless, HIV-positive 
status, severe disease and smear positivity were associated 
with minimal improvement in HRQoL scores by the end of  
intensive phase.
Conclusion
All aspects of  quality of  life is affected but the emotional 
domain is the least affected in patients on treatment for 
tuberculosis. Younger patients with no physical impairment 
are more likely to default treatment. HRQoL assessment 
could form a veritable tool for patients’ evaluation and 
outcome measure in DOTS. We hereby recommend that 
attempts should be made to address concerns of  emotional 
problems and anxiety mainly due to stigma and fear of  
rejection, during care giving sessions especially in DOTS 
settings. We also recommend that individuals with high 
physical function score must be recognized and should 
receive personalized counsel at recruitment to encourage 
adherence to therapy. Pharmacy based programmes are also 
an area for further study within our context. A shorter form 
of  the HRQoL questionnaires may need to be introduced 
into DOTS clinics and scores that are highly discriminant 
of  defaulters obtained to ascertain patients who need closer 
monitoring. This may be a novel way of  dealing with the 
issue of  default in TB treatment.
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